Michael P. DeNinno

Person

Wildwood, IL, US

People

Patents Grantslast 30 patents

Information Patent Grant
Triazoles for the treatment of demyelinating dieases
- Patent number 10,766,869
- Issue date Sep 8, 2020
- VERTEX PHARMACEUTCALS INCORPORATED
- Robert J. Davies
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Chroman-spirocyclic piperidine amides as modulators of ion channels
- Patent number 10,385,070
- Issue date Aug 20, 2019
- Vertex Pharmaceuticals Incorporated
- Sara Sabina Hadida-Ruah
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Fused piperidine amides as modulators of ion channels
- Patent number 10,233,191
- Issue date Mar 19, 2019
- Vertex Pharmaceuticals Incorporated
- Michael Paul Deninno
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Triazoles for the treatment of Demyelinating Diseases
- Patent number 10,118,904
- Issue date Nov 6, 2018
- Vertex Pharmaceuticals Incorporated
- Robert J. Davies
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pyran-spirocyclic piperidine amides as modulators of ion channels
- Patent number 9,403,839
- Issue date Aug 2, 2016
- Vertex Pharmaceuticals Incorporated
- Sara Sabina Hadida-Ruah
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Morpholine-spirocyclic piperidine amides as modulators of ion channels
- Patent number 9,181,273
- Issue date Nov 10, 2015
- Vertex Pharmaceuticals Incorporated
- Sara Sabina Hadida-Ruah
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Morpholine-spirocyclic piperidine amides as modulators of ion channels
- Patent number 8,828,996
- Issue date Sep 9, 2014
- Vertex Pharmaceuticals Incorporated
- Sara Sabina Hadida-Ruah
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
4-carboxyamino-2-substituted-1,2,3,4-tetrahydroquinolines
- Patent number 6,906,082
- Issue date Jun 14, 2005
- Pfizer Inc.
- Michael P. DeNinno
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds for the treatment of ischemia
- Patent number 6,803,457
- Issue date Oct 12, 2004
- Pfizer, Inc.
- Michael P. DeNinno
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
4-carboxyamino-2-substituted-1,2,3,4-tetrahydroquinolines
- Patent number 6,586,448
- Issue date Jul 1, 2003
- Pfizer Inc.
- Michael P. DeNinno
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
4-amino substituted-2-substituted-1,2,3,4-tetrahydroquinolines
- Patent number 6,489,478
- Issue date Dec 3, 2002
- Pfizer Inc.
- Michael P. DeNinno
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
4-carboxyamino-2-methyl-1,2,3,4,-tetrahydroquinolines
- Patent number 6,395,751
- Issue date May 28, 2002
- Pfizer Inc.
- Michael P. DeNinno
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Annulated 4-carboxyamino-2-methyl-1,2,3,4-tetrahydroquinolines
- Patent number 6,310,075
- Issue date Oct 30, 2001
- Pfizer Inc.
- Michael P. DeNinno
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
4-Carboxyamino-2-substituted-1,2,3,4-tetrahydroquinolines
- Patent number 6,197,786
- Issue date Mar 6, 2001
- Pfizer Inc.
- Michael P. DeNinno
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Steroidal glycosides
- Patent number 6,150,336
- Issue date Nov 21, 2000
- Pfizer Inc.
- Michael P. Deninno
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
4-carboxyamino-2-methyl-1,2,3,4,-tetrahydroquinolines
- Patent number 6,147,090
- Issue date Nov 14, 2000
- Pfizer Inc.
- Michael P. DeNinno
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Annulated 4-carboxyamino-2-methyl-1,2,3,4,-tetrahydroquinolines
- Patent number 6,147,089
- Issue date Nov 14, 2000
- Pfizer Inc.
- Michael P. DeNinno
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
4-amino substituted-2-substituted-1,2,3,4-tetrahydroquinolines
- Patent number 6,140,343
- Issue date Oct 31, 2000
- Pfizer
- Michael P. DeNinno
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Hypocholesterolemic agents
- Patent number 5,939,398
- Issue date Aug 17, 1999
- Pfizer Inc.
- Michael Paul Deninno
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Spirostanyl glycosidal crystals
- Patent number 5,804,562
- Issue date Sep 8, 1998
- Pfizer Inc.
- Douglas John Allen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Sterodial glycosides for treating hypercholesterolemia
- Patent number 5,703,052
- Issue date Dec 30, 1997
- Pfizer Inc.
- Michael Paul Deninno
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Steroidal glycosides
- Patent number 5,698,526
- Issue date Dec 16, 1997
- Pfizer Inc.
- Michael Paul Deninno
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Steroidal glycosides for treating hypercholesterolemia
- Patent number 5,629,295
- Issue date May 13, 1997
- Pfizer Inc.
- Michael P. Deninno
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Dopamine agonists
- Patent number 5,621,133
- Issue date Apr 15, 1997
- Michael P. DeNinno
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Dopamine agonists
- Patent number 5,591,884
- Issue date Jan 7, 1997
- Abbott Laboratories
- Michael P. DeNinno
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Dopaminergic compounds
- Patent number 4,994,486
- Issue date Feb 19, 1991
- Abbott Laboratories
- Robert W. Schoenleber
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Dopamine agonists
- Patent number 4,963,568
- Issue date Oct 16, 1990
- Abbott Laboratories
- Robert W. Schoenleber
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
PI3K-ALPHA INHIBITORS AND METHODS OF USE THEREOF
- Publication number 20250019380
- Publication date Jan 16, 2025
- Relay Therapeutics, Inc.
- Alessandro BOEZIO
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PI3K-ALPHA INHIBITORS AND METHODS OF USE THEREOF
- Publication number 20240287058
- Publication date Aug 29, 2024
- Relay Therapeutics, Inc.
- Alessandro BOEZIO
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
7- OR 8-HYDROXY-ISOQUINOLINE AND 7- OR 8-HYDROXY-QUINOLINE DERIVATI...
- Publication number 20230159504
- Publication date May 25, 2023
- VERTEX PHARMACEUTICALS INCORPORATED
- Simon GIROUX
- C07 - ORGANIC CHEMISTRY
Information Patent Application
1H-PYRAZOLO[4,3-G]ISOQUINOLINE AND 1H-PYRAZOLO[4,3-G]QUINOLINE DERI...
- Publication number 20230159521
- Publication date May 25, 2023
- VERTEX PHARMACEUTICALS INCORPORATED
- Simon GIROUX
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TRIAZOLES FOR THE TREATMENT OF DEMYELINATING DISEASES
- Publication number 20190185436
- Publication date Jun 20, 2019
- VERTEX PHARMACEUTICALS INCORPORATED
- Robert J. Davies
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TRIAZOLES FOR THE TREATMENT OF DEMYELINATING DISEASES
- Publication number 20160355488
- Publication date Dec 8, 2016
- VERTEX PHARMACEUTICALS INCORPORATED
- Robert J. Davies
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Fused Piperidine Amides as Modulators of Ion Channels
- Publication number 20160159815
- Publication date Jun 9, 2016
- VERTEX PHARMACEUTICALS INCORPORATED
- Michael Paul DENINNO
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MORPHOLINE-SPIROCYCLIC PIPERIDINE AMIDES AS MODULATORS OF ION CHANNELS
- Publication number 20150025073
- Publication date Jan 22, 2015
- VERTEX PHARMACEUTICALS INCORPORATED
- Sara Sabina Hadida-Ruah
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Pyran-Spirocyclic Piperidine Amides as Modulators of Ion Channels
- Publication number 20150005304
- Publication date Jan 1, 2015
- VERTEX PHARMACEUTICALS INCORPORATED
- Sara Sabina Hadida-Ruah
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MORPHOLINE-SPIROCYCLIC PIPERIDINE AMIDES AS MODULATORS OF ION CHANNELS
- Publication number 20120264749
- Publication date Oct 18, 2012
- Sara Sabina Hadida-Ruah
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CHROMAN-SPIROCYCLIC PIPERIDINE AMIDES AS MODULATORS OF ION CHANNELS
- Publication number 20120245136
- Publication date Sep 27, 2012
- Sara Sabina HADIDA-RUAH
- C07 - ORGANIC CHEMISTRY
Information Patent Application
3-OXA-7-AZABICYCLO[3.3.1]NONANES
- Publication number 20120095028
- Publication date Apr 19, 2012
- Pfizer Inc.
- Michael Paul DeNinno
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
GPR 119 MODULATORS
- Publication number 20120052130
- Publication date Mar 1, 2012
- Pfizer Inc.
- Etzer Darout
- C07 - ORGANIC CHEMISTRY
Information Patent Application
GPR 119 MODULATORS
- Publication number 20100285145
- Publication date Nov 11, 2010
- Pfizer Inc.
- Etzer Darout
- C07 - ORGANIC CHEMISTRY
Information Patent Application
4-carboxyamino-2-substituted-1,2,3,4-tetrahydroquinolines
- Publication number 20050245570
- Publication date Nov 3, 2005
- Michael P. DeNinno
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Compounds for the treatment of ischemia
- Publication number 20050171049
- Publication date Aug 4, 2005
- Michael P. DeNinno
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PDE9 inhibitors for treating type 2 diabetes,metabolic syndrome, an...
- Publication number 20040220186
- Publication date Nov 4, 2004
- Pfizer Inc.
- Andrew Simon Bell
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Compounds for the treatment of ischemia
- Publication number 20040198693
- Publication date Oct 7, 2004
- Michael P. DeNinno
- C07 - ORGANIC CHEMISTRY
Information Patent Application
4-carboxyamino-2-substituted-1,2,3,4-tetrahydroquinolines
- Publication number 20040092550
- Publication date May 13, 2004
- Pfizer Inc.
- Michael P. DeNinno
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PDE9 inhibitors for treating cardiovascular disorders
- Publication number 20030195205
- Publication date Oct 16, 2003
- Pfizer Inc.
- Michael Paul DeNinno
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Compounds for the treatment of ischemia
- Publication number 20030055021
- Publication date Mar 20, 2003
- Michael P. DeNinno
- C07 - ORGANIC CHEMISTRY

Michael P. DeNinno

Person

Patents Grantslast 30 patents

Triazoles for the treatment of demyelinating dieases

Chroman-spirocyclic piperidine amides as modulators of ion channels

Fused piperidine amides as modulators of ion channels

Triazoles for the treatment of Demyelinating Diseases

Pyran-spirocyclic piperidine amides as modulators of ion channels

Morpholine-spirocyclic piperidine amides as modulators of ion channels

Morpholine-spirocyclic piperidine amides as modulators of ion channels

4-carboxyamino-2-substituted-1,2,3,4-tetrahydroquinolines

Compounds for the treatment of ischemia

4-carboxyamino-2-substituted-1,2,3,4-tetrahydroquinolines

4-amino substituted-2-substituted-1,2,3,4-tetrahydroquinolines

4-carboxyamino-2-methyl-1,2,3,4,-tetrahydroquinolines

Annulated 4-carboxyamino-2-methyl-1,2,3,4-tetrahydroquinolines

4-Carboxyamino-2-substituted-1,2,3,4-tetrahydroquinolines

Steroidal glycosides

4-carboxyamino-2-methyl-1,2,3,4,-tetrahydroquinolines

Annulated 4-carboxyamino-2-methyl-1,2,3,4,-tetrahydroquinolines

4-amino substituted-2-substituted-1,2,3,4-tetrahydroquinolines

Hypocholesterolemic agents

Spirostanyl glycosidal crystals

Sterodial glycosides for treating hypercholesterolemia

Steroidal glycosides

Steroidal glycosides for treating hypercholesterolemia

Dopamine agonists

Dopamine agonists

Dopaminergic compounds

Dopamine agonists

Patents Applicationslast 30 patents

PI3K-ALPHA INHIBITORS AND METHODS OF USE THEREOF

PI3K-ALPHA INHIBITORS AND METHODS OF USE THEREOF

7- OR 8-HYDROXY-ISOQUINOLINE AND 7- OR 8-HYDROXY-QUINOLINE DERIVATI...

1H-PYRAZOLO[4,3-G]ISOQUINOLINE AND 1H-PYRAZOLO[4,3-G]QUINOLINE DERI...

TRIAZOLES FOR THE TREATMENT OF DEMYELINATING DISEASES

TRIAZOLES FOR THE TREATMENT OF DEMYELINATING DISEASES

Fused Piperidine Amides as Modulators of Ion Channels

MORPHOLINE-SPIROCYCLIC PIPERIDINE AMIDES AS MODULATORS OF ION CHANNELS

Pyran-Spirocyclic Piperidine Amides as Modulators of Ion Channels

MORPHOLINE-SPIROCYCLIC PIPERIDINE AMIDES AS MODULATORS OF ION CHANNELS

CHROMAN-SPIROCYCLIC PIPERIDINE AMIDES AS MODULATORS OF ION CHANNELS

3-OXA-7-AZABICYCLO[3.3.1]NONANES

GPR 119 MODULATORS

GPR 119 MODULATORS

4-carboxyamino-2-substituted-1,2,3,4-tetrahydroquinolines

Compounds for the treatment of ischemia

PDE9 inhibitors for treating type 2 diabetes,metabolic syndrome, an...

Compounds for the treatment of ischemia

4-carboxyamino-2-substituted-1,2,3,4-tetrahydroquinolines

PDE9 inhibitors for treating cardiovascular disorders

Compounds for the treatment of ischemia